Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review
Toby A. Eyre(Oxford University Hospitals NHS Trust), Graham P. Collins(Churchill Hospital), Amy A. Kirkwood(Cancer Research UK), Faouzi Djebbari(Oxford University Hospitals NHS Trust)
Cited by 70
Related Papers
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
|The Lancet|2021|456
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2023|213
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
|New England Journal of Medicine|2023|155